Market Place
Sourcing Support
US firm enters patent settlement deal with Dr Reddy`s for Qsymia drug
01 Sep 2017 //
BUSINESS-STANDARD
Enforcement Report - Week of August 23, 2017
23 Aug 2017 //
FDA
Zydus Pharm’s Generic Phentermine Hydrochloride Receives Approval In US
30 Jun 2017 //
FDA
Kvk Tech Inc Generic Phentermine Hydrochloride Receives Approval In US
17 Mar 2017 //
FDA
Polygen`s Generic Phentermine HCL Receiives Approval In US
18 Nov 2016 //
FDA
Avanthi Inc Generic Phentermine Hydrochloride Approved In US
13 Sep 2016 //
FDA
Future obesity drugs must provide improved efficacy & safety,says GBI Research
17 Dec 2015 //
CPHI-ONLINE
More formulary exclusion are on their way as smaller PBMs get in the action
02 Dec 2015 //
FIERCE PHARMA
Are Takeda`s 900 Contrave reps worth it? Maybe not, analyst says
09 Nov 2015 //
FIERCE PHARMA MARKETING
Vivus counts $25M in Q3 sales, $300M in debt
05 Nov 2015 //
FIERCE PHARMA
Investors cheer as Arena forces out CEO and cofounder
06 Oct 2015 //
FIERCE PHARMA
Express Scripts stiff-arms AZ`s Onglyza, Vivus` Qsymia with new 2016 formulary
04 Aug 2015 //
FIERCE PHARMA
Flailing Vivus halves hard-hit Qsymia sales force as revenue lags
31 Jul 2015 //
FIERCE PHARMA
Vivus Files Lawsuit Against Teva For Infringement Of Qsymia Patents
16 Apr 2015 //
EIN NEWSDESK
Vivus Goes on a Diet: Sales Reps are Cut, but Will FDA Help Save Money?
02 Apr 2015 //
PHARMALOT
Is Europe Softening on Diet Drugs?
28 Mar 2015 //
MEDPAGE TODAY
Eisai Gets EMA Nod For Lenvima Just Weeks After FDA Approval
28 Mar 2015 //
FIERCE PHARMA
Weight-Loss Drugs Seek Acceptance From Patients and Physicians
17 Mar 2015 //
THE WALL STREET JOURNAL
Endo ends Stendra marketing pact, leaving Vivus in the lurch
05 Jan 2015 //
FIERCE PHARMA MARKETING
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.